Welcome Investors

The speed of revenue shift from legacy market segments to emerging break-through technology segments is astounding. When rapid in-vitro diagnostics will disrupt a $37 billion market - and Healthcare Providers Direct, Inc. will be there to change the rules of engagement for sales and distribution. We are positioned at the front end of a global market shift and we are addressing the fastest growing opportunities in the global IVD category.

In a growing market, some segments are losing share while others are gaining. HPD is situated in one of the fastest growing segments: the Point-of-Care diagnostic test segment for Professional testing by doctors at the patient's side. With a dozen test categories in the Professional Point-of-Care diagnostic test segment, our product line and new 2007 introductions will address all but one of these segments.

Mr. Norman Proulx
Chief Executive Officer and Chairman of the Board